In his personal capacity, Altman has invested in AI, energy, healthcare, finance, technology, cybersecurity, and other ...

Tyler Johnston has been compiling public data about OpenAI's operations for a year, and is now preparing a report to ...

That report, dubbed The OpenAI Files, is out today. It’s a collaboration between the Midas Project and the Tech Oversight Project, two nonprofit tech watchdog organizations, and it’s billed as the ...

The partnership, worth over US$35 million, will further develop MCRI's field-leading research and technology by licensing the blood stem cell discovery IP to Retro Biosciences for the development ...

According to its website, Retro BioScience focuses on “cellular reprogramming” and is less than four years away from developing a clinical proof-of-concept. It vows to extend human life by 10 ...

The final trailer of The Fantastic Four: First Steps sets the stage for an exciting battle between superheroes and a cosmic entity. Scheduled to release on July 25 worldwide, the events shown in the ...

At 50, Pedro Pascal has made his way to the top of every director’s wish list while also becoming a sex symbol. A funny, sad, ...

Georgia-raised country performer Willow Avalon talks about vintage dresses, her keys to survival and her album "Southern ...

Pacific Biosciences (PACB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced new data from the Phase 4 KINECT-PROTM open-label study demonstrating robust and sustained improvements in physical, social and ...

Net Margin: Neurocrine Biosciences's net margin is impressive, surpassing industry averages. With a net margin of 1.38%, the company demonstrates strong profitability and effective cost management.